Keywords: Amgen, Prolia, Osteoporosis in men, USA, FDA

Amgen's Prolia gets FDA nod for men with osteoporosis

Article | 24 September 2012

Print This

The US Food and Drug Administration last week approved a new indication for world biotech leader Amgen’s (Nasdaq: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in